SGMO Stock Analysis: Buy, Sell, or Hold?
SGMO - Sangamo Therapeutics, Inc. Common Stock
$0.18
0.04 (31.56%)
▲
5d:
-15.43%
30d:
-40.82%
90d:
-68.73%
WAIT
LOW Confidence
Analysis Updated: May 4, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When SGMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SGMO is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SGMO is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SGMO is currently trading at $0.18, which is considered fair based on recent price action.
Technical Outlook: Technically, SGMO is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.28. The stock is showing strong short-term momentum, up 31.6% recently.
Market Sentiment: SGMO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+2011.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SGMO is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.28. The stock is showing strong short-term momentum, up 31.6% recently.
Market Sentiment: SGMO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.75 (+2011.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+31.6%)
- BULLISH: Trading 2011.5% below Wall St target ($3.75)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.12
Resistance Level
$0.28
Current Trend
Strong Downtrend
Technical data as of
May 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.39
Wall Street Target
$3.75
(+2011.5%)
Revenue Growth (YoY)
88.4%
Share & Embed Analysis
Last updated: August 08, 2026 6:38 AM ET
Data refreshes hourly during market hours. Next update: 7:38 AM
Data refreshes hourly during market hours. Next update: 7:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGMO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Gregory D Davis
SELL
69827 shares
2026-04-22
Nathalie Dubois-Stringfe…
SELL
345942 shares
2026-04-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 51 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
